Article
Low-dose Imatinib Efficacy in a Gastrointestinal Stromal Tumor Patient With KIT Exon 11 W557_K558 Deletion.
In vivo (Athens, Greece) - 1 Jan 2000
Suto Hirotaka, Kawamura Miyuki, Morita Mitsunori, Sakai Hideki, Onoe Takuma, Ikeuchi Kyoko, Kajimoto Kazuyoshi, Matsumoto Koji
Abstract excerpt
BACKGROUND/AIM: Gastrointestinal stromal tumors (GISTs) are rare cancers originating from Cajal's stromal cells in the gastrointestinal tract. The most common driver mutation in these cancers is the KIT mutation. This report presents a case of response to low-dose imatinib in a patient with GIST harboring KIT exon 11 W557_K558 deletion. CASE REPORT: In June 2023, an 82-year-old male developed perineal pain....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.